Home » Elite Pharmaceuticals Announces FDA Approval of Supplemental Application for Naltrexone
Elite Pharmaceuticals Announces FDA Approval of Supplemental Application for Naltrexone
Elite Pharmaceuticals announced on Jan. 31, 2012, the FDA approved the company’s supplemental application for the manufacturing and packaging of naltrexone hydrochloride 50 mg tablets.
Yahoo! Medical News
Yahoo! Medical News
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May